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Abstract
Background: The Framingham Heart Study was initiated in 1948 as a long-term longitudinal study
to identify risk factors associated with cardiovascular disease (CVD). Over the years the scope of
the study has expanded to include offspring and other family members of the original cohort,
marker data useful for gene mapping and information on other diseases. As a result, it is a rich
resource for many areas of research going beyond the original goals. As part of the Genetic Analysis
Workshop 13, we used data from the study to evaluate the ability of neural networks to use CVD
risk factors as training data for predictions of normal and high blood pressure.
Results: Applying two different strategies to the coding of CVD risk data as risk factors (one
longitudinal and one independent of time), we found that neural networks could not be trained to
clearly separate individuals into normal and high blood pressure groups. When training was
successful, validation was not, suggesting over-fitting of the model. When the number of
parameters was reduced, training was not as good. An analysis of the input data showed that the
neural networks were, in fact, finding consistent patterns, but that these patterns were not
correlated with the presence or absence of high blood pressure.
Conclusion: Neural network analysis, applied to risk factors for CVD in the Framingham data, did
not lead to a clear classification of individuals into groups with normal and high blood pressure.
Thus, although high blood pressure may itself be a risk factor for CVD, it does not appear to be
clearly predictable using observations from a set of other CVD risk factors.
Background
Many of the risk factors for cardiovascular disease (CVD)
are now well known and widely accepted. Much of the
knowledge we have today can be attributed to the very
well planned longitudinal study initiated in 1948 by the
National Heart Institute (now the NHLBI) in the commu-
nity of Framingham, Massachusetts (the Framingham
Heart Study) [1]. One goal of the study was to identify the
common factors that contribute to CVD and to follow
these characteristics in a longitudinal cohort over many
years. The study has provided data for a variety of analyses
that probably exceed the original goals (see, e.g., [2,3]).
Data from the Framingham Heart Study were provided to
the participants of Genetic Analysis Workshop 13
(GAW13) and included measurements of CVD risk fac-
tors, taken over many years, on two cohorts from Fram-
ingham. The information provided did not include the
diagnosis of CVD itself. In the absence of direct CVD diag-
noses, we decided to look at the effect of many of the CVD
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pressure (HBP), in itself a risk factor and possibly a pre-
cursor to coronary problems. We used artificial neural net-
works to see if they could be trained to recognize a pattern
in CVD risk factors that might lead to high blood pressure.
(For obvious reasons, the blood pressure measurement
itself was excluded as a risk factor.) Two separate strategies
were employed. The first strategy, using data from both
the original cohort and the second cohort, defined
"classes" of phenotypic characteristics based on the data
gathered for each individual over the course of the study,
where the classes were defined based on current guide-
lines for "normal" or "abnormal" levels of the measure-
ments. The second strategy used data from the second,
"younger" cohort only, where fairly regular measurements
were made over five time intervals for all of the pheno-
typic risk factors. Each time interval for each individual
was considered an input record, with the outcome defined
as the presence or absence of HBP in that time interval.
Because of the nature of the models employed, training
and validating were limited to those individuals (or
records) where there was no treatment for high blood
pressure. The data were "normalized" to values between 0
and 1 so that no risk factor would dominate the training
of the neural network.
The first strategy resulted in a successfully "trained" net-
work that reliably classified those in the training set as
having normal or high blood pressure (BP). The valida-
tion on an independent data set was, however, not suc-
cessful. The data used with Strategy 2 did not even train
well (see below), suggesting that the input risk factors may
not, in fact, be reliable indicators of high blood pressure.
Methods
In the course of these analyses, two neural network pro-
grams were used for evaluation. One is NNdriver, devel-
oped in my laboratory [4]. The second is a freely available
program, SNNS, distributed by the University of Stuttgart
[5]. NNdriver makes use of a feed-forward back-propaga-
tion NN model and allows for multiple runs, where each
run randomly divides the data into training and valida-
tion sets. Results can then be averaged over all runs to get
a more accurate, representative outcome. SNNS has the
option of using other NN models as well as a feed-forward
back-propagation NN model. Here, we limited our runs to
the same model as that employed by NNdriver in order to
compare results from the two programs. We performed
several runs on independently selected random samples
using both programs. The results from both programs
were qualitatively similar, and different randomly
selected training and validation sets gave very similar
results. In general the number of hidden units in the sin-
gle hidden layer of the NN was set to be approximately
, where n is the number of input values. Runs were
also made with smaller or larger numbers of hidden units,
but the success rate did not increase. (For a general
description of the neural network models used here see
the appendix of Falk et al. [4]). In the results presented
below, representative runs are shown which illustrate the
qualitative outcome.
Strategy 1 (Cohorts 1 and 2)
A set of input factors was developed based on the longitu-
dinal progression of the various risk factors. A single
record was generated for each individual, based on the
range and values of the risk factors. All input values were
coded with a binary outcome. For example, one input fac-
tor represented the value of total cholesterol at the begin-
ning of the study. A code of 0 (zero) was assigned if total
cholesterol was <200. Otherwise a code of 1 (one) was
assigned. Table 1 shows the 25 input factors used, as well
as the division points between an assignment of 0 or 1.
A single output value was assigned based on whether the
individual had high blood pressure at any time during the
study. High blood pressure (as defined in the data set) is
present if systolic BP > 140 mm Hg or diastolic BP > 90
mm Hg. Only individuals who had not been treated for
high blood pressure were included. Both cohorts were
coded using this strategy, resulting in a total of 574
records for Cohort 1 and 1337 records for Cohort 2. Each
cohort was analyzed separately. In both cohorts the
number of individuals with high and low BP were quite
unbalanced. In Cohort 1 there were many more individu-
als with high BP than with normal BP, whereas in Cohort
2 the opposite was true. We found that simple random
samples with a preponderance of high or low BP records
tended to "train" well for the high frequency class and not
at all well for the low frequency class. Therefore samples
were selected from the total number of records available
so that the number of records with normal blood pressure
was approximately the same as the number of records
with high blood pressure. The selected records were then
randomly assigned to either the training or the validation
set for each run. Both NNdriver and SNNS were used for
training and validation. In the example shown below, 300
records were randomly selected for training and 300 for
validating the neural network. The data are from Cohort
2.
Strategy 2 (Cohort 2 only)
Records from all individuals in Cohort 2 were separated
into five (or fewer) records, one for each time period for
which measurements were made. Only time periods dur-
ing which the individual was not treated for high blood
pressure were included. This resulted in more than 6000
records. A single output value was assigned based on
whether the individual had high blood pressure for that
time period. Again, both NNdriver and SNNS were usednPage 2 of 6
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300 records were randomly selected for training and 300
for validating the neural network. Runs with larger sam-
ples gave qualitatively similar results. The sample was
again selected so that there was an equal number of
records with normal BP and high BP. Seven input values
were included in the training: sex; age; total cholesterol;
fasting glucose; fasting HDL; fasting triglycerides; body
mass index (BMI). All variables were "normalized" to val-
ues between zero and one so that no single factor would
dominate the training.
Results
Following training, a neural network produced a "pre-
dicted" outcome, given as a value between zero and one,
for each input record. A value < 0.5 is interpreted as a pre-
diction of normal BP and a value ≥ 0.5 as a prediction of
high BP. These predicted values can then be compared to
the actual classification of normal or high BP. In both of
the examples shown here, 300 randomly selected individ-
uals were used for training and 300 for validation.
Strategy 1
Training using this strategy typically resulted in success
rates of between 91 and 98% for the training set. Figure 1a
shows the results of one run, using data from Cohort 2,
where ~93% were correctly classified. The training model
had five hidden units and a "learn factor" of 0.01 (in
SNNS). The results show fairly good separation of the two
classes. Unfortunately, the success rate of the validation
set was much lower, only 59%, and the separation of the
two classes was not good. This lower rate for the valida-
tion set was typical of the results for this strategy, suggest-
ing that the trained network is not able to reliably predict
the outcome for newly encountered patterns. Figure 1b
shows the graph for the validation set corresponding to
the training set shown in Figure 1a. As can be seen, both
the high and normal BP individuals are distributed in
almost "S"-shaped curves, spanning both sides of the 0.5
y-axis. This is typical of "random" predicting, where the
data follow the shape of the transformation curve used in
the neural network.
Strategy 2
After training the network, the training set typically pre-
dicted high or normal BP correctly between 70 and 87%
of the time. However, an examination of the data shows
that the data were not distinctly separated into the two
classes. Figure 2a shows the distribution of results for a
representative training run, where 71% of the individuals
were "correctly" classified by the criterion given above.
The training model had two hidden units and a "learn fac-
tor" of 0.01. It is clear that there is no real difference
between the prediction curves of those with normal BP
Table 1: Coding of 25 Risk Factors for Strategy 1
Category Coded 0 Coded 1
Age at beginning ≥40 ≥40
Chol, beginning ≥200 ≥200
Chol, end ≥200 ≥200
Chol, change negative positive
Glu minimum <110 ≥110
Glu maximum ≥110 ≥110
LDL minimumA ≥130 ≥130
LDL maximumA ≥130 ≥130
HDL minimum ≥35 ≥35
HDL maximum ≥35 ≥35
Tri minimum ≥150 ≥150
Tri maximum ≥150 ≥150
BMI, beginningB ≥25 ≥25
BMI, endB ≥25 ≥25
BMI, changeB negative positive
Sex female male
3-column binary coding
cig smoked never always 1–20 >20 at any time
alcohol always < 10 g always 10–60 > 60 at any time
age at death alive (at last measure) ≥ 50 yrs 50 yrs
A LDL values were calculated from the standard formula: LDL = total cholesterol – HDL – Triglycerides/5. B BMI was calculated from the formula: 
BMI = 703 × Wt/(Ht)2 (Units in pounds and inches).Page 3 of 6
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and those with high BP. In the validation set for the same
run, 63% of the individuals were "correctly" classified
(Figure 2b). With Strategy 2 we were unable to design a
neural network that could be trained to distinctly separate
those with normal BP from those with high BP.
Discussion
Since HBP itself is considered to be a risk factor for CVD,
it would be useful to have a reliable method for predicting
the conditions that make one susceptible to HBP. In the
absence of a defined disease status for the Framingham
individuals, we chose to look at HBP as a preliminary con-
dition to see if we could identify patterns leading to HBP.
Unfortunately, the pattern of available risk factors for
CVD did not provide a reliable means of predicting high
blood pressure (HBP). The lack of success could be due to
one of several factors, including inappropriate design of
the neural networks or use of input information that does
not define risk patterns leading to high BP. In the case of
Strategy 1, the training results were generally quite good,
but could not be validated in independent data. This
suggests the possibility of over-fitting the data, i.e., using
a model with too many parameters. To test the theory of
over-fitting, we tested neural networks with fewer "hidden
nodes", leading to a smaller parameter set. The results
were essentially the same (or worse). In no case were we
able to demonstrate repeatability in a validation sample.
It is more difficult to determine if the input data are or are
not predictive of BP status. Strategy 1 looks promising, in
that the trained neural network did a good job of separat-
ing the data into high and normal BP classes. However,
the failure of validation suggests that the patterns are not
really describing conditions for high BP. Thus for these
data, despite seemingly "good" training, the neural net-
work did not correctly "predict" normal or high blood
pressure. It is tempting to speculate that a neural network
training approach would, in fact, be useful for predicting
the presence of CVD, using the same set of input risk fac-
tors. Unfortunately, without direct information about
CVD, we cannot say.
It is possible that another NN architecture would have
been more successful in classifying records into high and
normal BP classes. With SNNS one can select from a
number of NN models. However, NNdriver is restricted to
the feed-forward model, and we were interested in com-
paring results from the two programs. Limited time and
this interest in comparing the two programs encouraged
us to focus only on the well known feed-forward model.
Another interesting extension of the study would be to
compare the results of a NN analysis with those from a
more conventional regression analysis. Again, time con-
straints made this difficult. However, another GAW13
study [6] asked a similar question about the "association"
of BP status with CVD risk factors as well as with marker
data. They chose to use a very different approach, namely
a tree-based association model, to partition the data.
Interestingly, they also failed to detect an association
between high BP and the risk factors and marker data.
Conclusions
Neural network analysis, while perhaps useful for defin-
ing subsets of individuals with correlated patterns of risk
factors associated with CVD, does not seem to lead to a
clear classification of individuals into groups with normal
and high blood pressure. Thus, although high blood pres-
sure may be a risk factor for CVD, it does not appear to be
clearly predictable using a back propagation neural net-
work on observations from a set of other CVD risk factors.
It would be interesting to apply these methods to a sample
where the CVD status were known, as the risk factors are
most appropriate when used with the true disease status.
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